| Particulars |
|
|
|
| Company Name
| Hester Biosciences Ltd
| Year End
| 202403
|
| Full Year |
| Equity (₹ Cr.) |
8.51 |
B.V. (₹) |
382.50 |
| Sales(₹ Cr.) |
285.16 |
NP (₹ Cr.) |
27.14 |
| NP Var% |
-16.00 |
Div% |
60.00 |
| CPS(₹) |
43.40 |
EPS (₹) |
31.90 |
| Traded Value(₹ Lakhs) |
444.30 |
52 Week High |
3,375.00 |
| 52 Week Low |
1,247.00 |
Price BSE |
1,789.00 |
| Price NSE |
1,787.00 |
Market Capital (₹ Cr.) |
1,522.09 |
| P/C Ratio |
41.20 |
P/E Ratio |
56.10 |
| Price Vs.BV |
4.68 |
|
| Latest Quarter |
| Year End |
202412 |
Sales (₹ Cr.) |
62.83 |
| NP(₹ Cr.) |
4.44 |
NP Var % |
-31.00 |
| Trailing Twelve Months |
| Year End |
202412 |
Sales |
285.35 |
| OPM |
18.30 |
NP |
31.67 |
| NP Var% |
14.03 |
EPS |
34.84 |
| PE |
51.36 |
|
|